# Donepezil Versus Non-drug Treatment in Alzheimer's Disease.

> **NCT04661280** · PHASE3 · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 240 (estimated)

## Conditions studied

- Alzheimer Disease, Early Onset

## Interventions

- **DRUG:** Donepezil

## Key facts

- **NCT ID:** NCT04661280
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-10
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04661280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04661280, "Donepezil Versus Non-drug Treatment in Alzheimer's Disease.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04661280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*